Oncology News | pharmaphorum

News

Cancer immunotherapy pioneers awarded Nobel medicine prize

Cancer immunotherapy pioneers James Allison and Tasuku Honjo have been awarded this year’s Nobel Prize in Physiology or Medicine.

News

US regulator backs Pfizer's Vizimpro lung cancer drug

The US drug regulator has given Pfizer’s Vizimpro the green light in a group of lung cancer patients whose tumours have a certain mutation.

News

Roche buys Tusk, plus cancer immunotherapy drug, for £62m

Roche has bought immuno-oncology biotech firm Tusk Therapeutics for an upfront payment of £62 million.

News

Ipsen strengthens oncology R&D team with two experts

French pharma company Ipsen has hired two R&D leaders to boost the company’s oncology arm.

News

Frazier to stay on as Merck CEO, as company axes retirement ...

Merck & Co’s CEO Ken Frazier has received the strongest possible backing from the company’s board, after it was announced the pharma company has rescinded a mandatory retirement age pol

News

Latest lung cancer data could open new avenue for Roche's Te...

Roche is eyeing a new use for its checkpoint inhibitor immunotherapy Tecentriq after it posted results showing it extended patients’ lives by an extra two months compared with chemotherapy

Cancer immunotherapy pioneers awarded Nobel medicine prize

US regulator backs Pfizer's Vizimpro lung cancer drug

Roche buys Tusk, plus cancer immunotherapy drug, for £62m

Ipsen strengthens oncology R&D team with two experts

Frazier to stay on as Merck CEO, as company axes retirement ...

Latest lung cancer data could open new avenue for Roche's Te...

Parexel buys Vitrana to boost patient safety toolkit

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks